• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺微小乳头状癌的非侵入性诊断:基于核磁共振的代谢组学方法。

Non-invasive diagnosis of papillary thyroid microcarcinoma: a NMR-based metabolomics approach.

作者信息

Lu Jinghui, Hu Sanyuan, Miccoli Paolo, Zeng Qingdong, Liu Shaozhuang, Ran Lin, Hu Chunxiao

机构信息

Department of General Surgery, Qilu Hospital of Shandong University, Jinan 250012, P.R. China.

Department of General Surgery, University of Pisa, Pisa 56126, Italy.

出版信息

Oncotarget. 2016 Dec 6;7(49):81768-81777. doi: 10.18632/oncotarget.13178.

DOI:10.18632/oncotarget.13178
PMID:27835583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5348428/
Abstract

Papillary thyroid microcarcinoma (PTMC) is a subtype of papillary thyroid carcinoma (PTC). Because its diameter is less than 10 mm, diagnosing it accurately is difficult with traditional methods such as image examinations and FNA (Fine Needle Aspiration). Investigating the metabolic changes induced by PTMC may enhance the understanding of its pathogenesis and provide important information for a new diagnosis method and treatment plan. In this study, high resolution magic angle spin (HRMAS) spectroscopy and 1H-nuclear magnetic resonance (1H-NMR) spectroscopy were used to screen metabolic changes in thyroid tissues and plasma from PTMC patients respectively. The results revealed reduced levels of fatty acids and elevated levels of several amino acids (phenylalanine, tyrosine, lactate, serine, cystine, lysine, glutamine/glutamate, taurine, leucine, alanine, isoleucine and valine) in thyroid tissues, as well as reduced levels of amino acids such as valine, tyrosine, proline, lysine, leucine and elevated levels of glucose, mannose, pyruvate and 3-hydroxybutyrate in plasma, are involved in the metabolic alterations in PTMC. In addition, a receiver operating characteristic (ROC) curve model for PTMC prediction was able to classify cases with good sensitivity and specificity using 9 significant changed metabolites in plasma. This work illustrates that the NMR-based metabolomics approach is capable of providing more sensitive diagnostic results and more systematic therapeutic information for PTMC.

摘要

甲状腺微小乳头状癌(PTMC)是甲状腺乳头状癌(PTC)的一种亚型。由于其直径小于10毫米,使用传统方法如影像检查和细针穿刺抽吸活检(FNA)很难准确诊断。研究PTMC诱导的代谢变化可能会增进对其发病机制的理解,并为新的诊断方法和治疗方案提供重要信息。在本研究中,分别使用高分辨率魔角旋转(HRMAS)光谱和1H核磁共振(1H-NMR)光谱来筛选PTMC患者甲状腺组织和血浆中的代谢变化。结果显示,甲状腺组织中脂肪酸水平降低,几种氨基酸(苯丙氨酸、酪氨酸、乳酸、丝氨酸、胱氨酸、赖氨酸、谷氨酰胺/谷氨酸、牛磺酸、亮氨酸、丙氨酸、异亮氨酸和缬氨酸)水平升高,以及血浆中缬氨酸、酪氨酸、脯氨酸、赖氨酸、亮氨酸等氨基酸水平降低,葡萄糖、甘露糖、丙酮酸和3-羟基丁酸水平升高,这些都参与了PTMC的代谢改变。此外,基于血浆中9种显著变化的代谢物建立的PTMC预测的受试者工作特征(ROC)曲线模型能够以良好的敏感性和特异性对病例进行分类。这项工作表明,基于核磁共振的代谢组学方法能够为PTMC提供更敏感的诊断结果和更系统的治疗信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e050/5348428/89d4af3db7e6/oncotarget-07-81768-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e050/5348428/554410f1d414/oncotarget-07-81768-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e050/5348428/8a459b624cc9/oncotarget-07-81768-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e050/5348428/2b2401cf4c00/oncotarget-07-81768-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e050/5348428/bb3af53056c7/oncotarget-07-81768-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e050/5348428/da376798fc27/oncotarget-07-81768-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e050/5348428/d612c422abb3/oncotarget-07-81768-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e050/5348428/89d4af3db7e6/oncotarget-07-81768-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e050/5348428/554410f1d414/oncotarget-07-81768-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e050/5348428/8a459b624cc9/oncotarget-07-81768-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e050/5348428/2b2401cf4c00/oncotarget-07-81768-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e050/5348428/bb3af53056c7/oncotarget-07-81768-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e050/5348428/da376798fc27/oncotarget-07-81768-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e050/5348428/d612c422abb3/oncotarget-07-81768-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e050/5348428/89d4af3db7e6/oncotarget-07-81768-g007.jpg

相似文献

1
Non-invasive diagnosis of papillary thyroid microcarcinoma: a NMR-based metabolomics approach.甲状腺微小乳头状癌的非侵入性诊断:基于核磁共振的代谢组学方法。
Oncotarget. 2016 Dec 6;7(49):81768-81777. doi: 10.18632/oncotarget.13178.
2
Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma.血清 microRNAs 联合超声特征作为甲状腺微小乳头状癌诊断和预后的预测生物标志物。
Oncol Rep. 2018 Dec;40(6):3611-3624. doi: 10.3892/or.2018.6776. Epub 2018 Oct 9.
3
Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.利用超声引导下细针穿刺活检样本的蛋白质组学分析破译甲状腺乳头状微癌淋巴结转移的新型生物标志物。
J Proteomics. 2019 Jul 30;204:103414. doi: 10.1016/j.jprot.2019.103414. Epub 2019 Jun 10.
4
Metabolic changes associated with papillary thyroid carcinoma: A nuclear magnetic resonance-based metabolomics study.与甲状腺乳头癌相关的代谢变化:基于核磁共振的代谢组学研究。
Int J Mol Med. 2018 May;41(5):3006-3014. doi: 10.3892/ijmm.2018.3494. Epub 2018 Feb 16.
5
Plasma metabolites analysis of patients with papillary thyroid cancer: A preliminary untargeted H NMR-based metabolomics.甲状腺乳头状癌患者的血浆代谢产物分析:基于核磁共振的初步非靶向代谢组学研究
J Pharm Biomed Anal. 2024 Apr 15;241:115946. doi: 10.1016/j.jpba.2023.115946. Epub 2023 Dec 28.
6
Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.甲状腺乳头状癌组织的代谢组学:诊断的潜在生物标志物及有前景的治疗靶点
Tumour Biol. 2016 Aug;37(8):11163-75. doi: 10.1007/s13277-016-4996-z. Epub 2016 Mar 2.
7
Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma.术前超声检查和血清促甲状腺激素对预测甲状腺微小乳头状癌或可疑甲状腺微小乳头状癌甲状腺结节中央淋巴结转移的价值
Tumour Biol. 2016 Jun;37(6):7453-9. doi: 10.1007/s13277-015-4535-3. Epub 2015 Dec 17.
8
Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.血清-血浆匹配代谢组学全面分析甲状腺良性结节和甲状腺乳头状癌。
Int J Cancer. 2019 Feb 15;144(4):868-876. doi: 10.1002/ijc.31925. Epub 2018 Dec 3.
9
Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic?甲状腺微小乳头状癌:如何诊断与处理这一流行病?
Int J Surg Pathol. 2014 Apr;22(2):113-9. doi: 10.1177/1066896913517394. Epub 2014 Jan 7.
10
Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.甲状腺微小乳头状癌甲状腺外侵犯相关的临床病理、免疫组化因素及复发情况
J Cancer Res Ther. 2014 Jan-Mar;10(1):50-5. doi: 10.4103/0973-1482.131366.

引用本文的文献

1
Single-cell RNA sequencing and multi-omics analysis of prognosis-related staging in papillary thyroid cancer.甲状腺乳头状癌预后相关分期的单细胞RNA测序和多组学分析
Cancer Immunol Immunother. 2025 Jul 12;74(8):267. doi: 10.1007/s00262-025-04101-4.
2
Non-invasive diagnosis of papillary thyroid microcarcinoma using a novel metabolomics analysis of urine.利用尿液的新型代谢组学分析对甲状腺微小乳头状癌进行无创诊断。
Endocrine. 2025 Mar;87(3):1100-1111. doi: 10.1007/s12020-024-04105-7. Epub 2024 Nov 24.
3
Construction and validation of a diagnostic model for high-risk papillary thyroid microcarcinoma.

本文引用的文献

1
[An introduction of surgical update in 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer].[2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌患者管理指南中的手术进展介绍]
Zhonghua Wai Ke Za Zhi. 2016 Mar 1;54(3):172-6. doi: 10.3760/cma.j.issn.0529-5815.2016.03.004.
2
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
3
构建并验证高危型甲状腺微小乳头状癌的诊断模型。
Front Endocrinol (Lausanne). 2024 Oct 9;15:1431584. doi: 10.3389/fendo.2024.1431584. eCollection 2024.
4
Editorial: Molecular characterization of thyroid lesions in the era of "next generation" techniques: volume II.社论:“下一代”技术时代甲状腺病变的分子特征:第二卷
Front Endocrinol (Lausanne). 2024 Jul 29;15:1460239. doi: 10.3389/fendo.2024.1460239. eCollection 2024.
5
Identifying potential breath biomarkers for early diagnosis of papillary thyroid cancer based on solid-phase microextraction gas chromatography-high resolution mass spectrometry with metabolomics.基于固相微萃取气相色谱-高分辨质谱联用代谢组学技术鉴定甲状腺乳头状癌早期诊断的潜在呼吸生物标志物。
Metabolomics. 2024 May 21;20(3):59. doi: 10.1007/s11306-024-02119-w.
6
Metabolomic screening of radioiodine refractory thyroid cancer patients and the underlying chemical mechanism of iodine resistance.放射性碘难治性甲状腺癌患者的代谢组学筛选及碘耐药的潜在化学机制。
Sci Rep. 2024 May 8;14(1):10546. doi: 10.1038/s41598-024-61067-6.
7
Metabolite signature of human malignant thyroid tissue: A systematic review and meta-analysis.人类恶性甲状腺组织的代谢物特征:系统评价和荟萃分析。
Cancer Med. 2024 Apr;13(8):e7184. doi: 10.1002/cam4.7184.
8
Significant dysregulation of lipid metabolism in patients with papillary thyroid carcinoma after thyroidectomy.甲状腺癌患者甲状腺切除术后脂质代谢显著失调。
Front Endocrinol (Lausanne). 2023 Oct 12;14:1223527. doi: 10.3389/fendo.2023.1223527. eCollection 2023.
9
Insight of novel biomarkers for papillary thyroid carcinoma through multiomics.通过多组学洞察甲状腺乳头状癌的新型生物标志物
Front Oncol. 2023 Sep 19;13:1269751. doi: 10.3389/fonc.2023.1269751. eCollection 2023.
10
Alterations in the amino acid profile in patients with papillary thyroid carcinoma with and without Hashimoto's thyroiditis.伴有和不伴有桥本甲状腺炎的甲状腺乳头癌患者氨基酸谱的变化。
Front Endocrinol (Lausanne). 2023 Aug 18;14:1199291. doi: 10.3389/fendo.2023.1199291. eCollection 2023.
Application of metabolomics in thyroid cancer research.代谢组学在甲状腺癌研究中的应用。
Int J Endocrinol. 2015;2015:258763. doi: 10.1155/2015/258763. Epub 2015 Apr 20.
4
MetaboAnalyst 3.0--making metabolomics more meaningful.MetaboAnalyst 3.0——让代谢组学更具意义。
Nucleic Acids Res. 2015 Jul 1;43(W1):W251-7. doi: 10.1093/nar/gkv380. Epub 2015 Apr 20.
5
Follicular adenomas exhibit a unique metabolic profile. ¹H NMR studies of thyroid lesions.滤泡性腺瘤具有独特的代谢特征。甲状腺病变的¹H NMR研究。
PLoS One. 2013 Dec 23;8(12):e84637. doi: 10.1371/journal.pone.0084637. eCollection 2013.
6
Application of ggplot2 to Pharmacometric Graphics.ggplot2 在药代动力学图形中的应用。
CPT Pharmacometrics Syst Pharmacol. 2013 Oct 16;2(10):e79. doi: 10.1038/psp.2013.56.
7
Neuroprotective effects of Huang-Lian-Jie-Du-Decoction on ischemic stroke rats revealed by (1)H NMR metabolomics approach.基于(1)H NMR 代谢组学方法研究黄连解毒汤对缺血性脑卒中大鼠的神经保护作用。
J Pharm Biomed Anal. 2014 Jan;88:106-16. doi: 10.1016/j.jpba.2013.08.025. Epub 2013 Aug 29.
8
Discrimination between genetically identical peony roots from different regions of origin based on 1H-nuclear magnetic resonance spectroscopy-based metabolomics: determination of the geographical origins and estimation of the mixing proportions of blended samples.基于1H-核磁共振光谱代谢组学鉴别不同产地的基因相同的牡丹根:地理来源的确定及混合样品混合比例的估计
Anal Bioanal Chem. 2013 Sep;405(23):7523-34. doi: 10.1007/s00216-013-7182-9. Epub 2013 Jul 16.
9
Metabolomics approach to thyroid nodules: a high-resolution magic-angle spinning nuclear magnetic resonance-based study.基于高分辨魔角旋转核磁共振的甲状腺结节代谢组学研究。
Surgery. 2012 Dec;152(6):1118-24. doi: 10.1016/j.surg.2012.08.037.
10
Toward the reliable diagnosis of indeterminate thyroid lesions: a HRMAS NMR-based metabolomics case of study.迈向不确定甲状腺病变的可靠诊断:基于高分辨魔角旋转核磁共振的代谢组学研究案例
J Proteome Res. 2012 Jun 1;11(6):3317-25. doi: 10.1021/pr300105e. Epub 2012 May 4.